Skip to Content
Series

Pfizer CEO Albert Bourla reflects on unprecedented vaccine development

February 02, 2021 00:00 AM UTC
- Updated February 03, 2021 18:50 PM UTC

Fortune Editor-in-Chief Clifton Leaf talks with Bourla about the remarkable development process.